Hopp til hovedinnhold

Kalsiumpyrofosfat avleiring

Sist revidert:
Sist revidert av:

  1. Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011;70:571-575. PMID: 21257614 PubMed  
  2. Zhang W, Doherty M, Bardin T, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011; 70:563. PubMed  
  3. Cowley S, McCarthy G. Diagnosis and Treatment of Calcium Pyrophosphate Deposition (CPPD) Disease: A Review. Open Access Rheumatol. 2023 Mar 22;15:33-41. PMID: 36987530. PubMed  
  4. Wilkins E, Dieppe P, Maddison P, et al. Osteoarthritis and articular chondrocalcinosis in the elderly. Ann Rheum Dis. 1983;42:280-284. PMID: 6859960 PubMed  
  5. Neame R, Carr A, Muir K, et al. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis. 2003;62:513-518. PMID: 12759286 PubMed  
  6. Tedeschi S. Identifying potential classification criteria for calcium pyrophosphate deposition disease: item generation and item reduction. Arthritis Care Res. 2021;10:1002. PubMed  
  7. Miksanek J, Rosenthal AK. Imaging of calcium pyrophosphate deposition disease. Curr Rheumatol Rep. 2015;17(3):20. PubMed  
  8. Cipolletta E, Filippucci E, Abhishek A, et al. In patients with acute mono/oligoarthritis, a targeted ultrasound scanning protocol shows great accuracy for the diagnosis of gout and CPPD. Rheumatology (Oxford). 2023;62(4):1493-1500. PubMed  
  9. Grassi W, Okano T, Filippucci E. Use of ultrasound for diagnosis and monitoring of outcomes in crystal arthropathies. Curr Opin Rheumatol. 2015;27(2):147–155. PMID: 25633243 PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim